Cargando…
Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage
Subarachnoid hemorrhage after the rupture of a cerebral aneurysm is the cause of 6% to 8% of all cerebrovascular accidents involving 10 of 100,000 people each year. Despite effective treatment of the aneurysm, delayed cerebral ischemia (DCI) is observed in 30% of patients, with a peak on the tenth d...
Autores principales: | Castanares-Zapatero, Diego, Hantson, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224484/ https://www.ncbi.nlm.nih.gov/pubmed/21906344 http://dx.doi.org/10.1186/2110-5820-1-12 |
Ejemplares similares
-
Angiopoietin-1 is associated with cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage
por: Fischer, Marlene, et al.
Publicado: (2011) -
The impact of collateral status on cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage
por: Topcu, Abdullah, et al.
Publicado: (2023) -
Non-cerebral vasospasm factors and cerebral vasospasm predict delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
por: Chen, Yue, et al.
Publicado: (2022) -
Therapeutic Implications of Estrogen for Cerebral Vasospasm and Delayed Cerebral Ischemia Induced by Aneurysmal Subarachnoid Hemorrhage
por: Ding, Dale, et al.
Publicado: (2014) -
Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
por: Dankbaar, Jan W., et al.
Publicado: (2009)